Evidence map›Paper›PMID 34402945›Full record

GuidelineWorld journal of urology2022

Prioritization of risk situations in neuro-urology: guidelines from Association Française d'Urologie (AFU), Association Francophone Internationale des Groupes d'Animation de la Paraplégie (A.F.I.G.A.P.), Groupe de Neuro-urologie de Langue Française (GENULF), Société Française de Médecine Physique et de Réadaptation (SOFMER) and Société Interdisciplinaire Francophone d'UroDynamique et de Pelvi-Périnéologie (SIFUD-PP).

Claire Hentzen, Xavier Biardeau, Nicolas Turmel, Rebecca Haddad, Elsa Bey, Gérard Amarenco, Pierre Denys, Véronique Phé, Marie Aimée Perrouin-Verbe, Benoit Peyronnet and 1 more

Abstract readPractice Guideline
In one paragraph

Guideline in World journal of urology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Claire HentzenDepartment of Neuro-Urology, Sorbonne University, GRC 01, GREEN Group of Clinical REsEarch in Neurourology, AP-HP, Hôpital Tenon, 4, rue de la Chine, 75020, Paris, France. claire.hentzen.mpr@gmail.com.ORCID http://orcid.org/0000-0002-9223-4925
Xavier BiardeauDepartment of Urology, University of Lille, Claude Huriez Hospital, CHU Lille, 59000, Lille, France.ORCID http://orcid.org/0000-0003-1270-7401
Nicolas TurmelDepartment of Neuro-Urology, Sorbonne University, GRC 01, GREEN Group of Clinical REsEarch in Neurourology, AP-HP, Hôpital Tenon, 4, rue de la Chine, 75020, Paris, France.ORCID http://orcid.org/0000-0002-4838-5996
Rebecca HaddadDepartment of Neuro-Urology, Sorbonne University, GRC 01, GREEN Group of Clinical REsEarch in Neurourology, AP-HP, Hôpital Tenon, 4, rue de la Chine, 75020, Paris, France.ORCID http://orcid.org/0000-0002-1528-5569
Elsa BeyUrology and Andrology Department, Nîmes University Hospital, University of Montpellier, Nîmes, France.ORCID http://orcid.org/0000-0003-4713-763X
Gérard AmarencoDepartment of Neuro-Urology, Sorbonne University, GRC 01, GREEN Group of Clinical REsEarch in Neurourology, AP-HP, Hôpital Tenon, 4, rue de la Chine, 75020, Paris, France.ORCID http://orcid.org/0000-0001-8067-7983
Pierre DenysNeurourology and Andrology Unit, Department of Physical Medecine and Rehabilitation, Raymond-Poincaré, AP-HP, Université Paris-Saclay, UMR 1179 Inserm, Paris, France.ORCID http://orcid.org/0000-0002-4831-6499
Véronique PhéDepartment of Urology, Sorbonne University, AP-HP, Pitié-Salpêtrière Academic Hospital, Paris, France.ORCID http://orcid.org/0000-0002-4997-6763
Marie Aimée Perrouin-VerbeUrology department, Hôtel Dieu Hospital, University of Nantes, Nantes, France.ORCID http://orcid.org/0000-0002-0212-2840
Benoit PeyronnetDepartment of Urology, University of Rennes, Rennes, France.
Charles JoussainNeurourology and Andrology Unit, Department of Physical Medecine and Rehabilitation, Raymond-Poincaré, AP-HP, Université Paris-Saclay, UMR 1179 Inserm, Paris, France.ORCID http://orcid.org/0000-0002-5467-599X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe current health crisis has drastically impacted patient management in many fields, including neuro-urology, leading to a mandatory reorganization. The aim of this work was to establish guidelines regarding the prioritization and optimal timing of each step of neurogenic lower urinary tract dysfunction management.

methodsA steering committee included urologists and physical medicine and rehabilitation practitioners. Based on a literature review and their own expertise, they established a comprehensive risk-situation list and built a risk scale, allowing multiple other experts to score each clinical situation. New recommendations were generated using a Delphi process approach.

resultsForty-nine experts participated in the rating group. Among the 206 initial items, 163 were selected and divided into four domains, diagnosis and assessment, treatment, follow-up, and complications, and two sub-domains, general (applicable for all neurological conditions) and condition-specific [varying according to the neurological condition (spinal cord injury, multiple sclerosis, brain injury, Parkinsonism, dysraphism, lower motor neuron lesions)]. The resulted guidelines are expert opinions established by a panel of French-speaking specialists, which could limit the scalability of this work.

conclusionsThe present multidisciplinary collaborative work generates recommendations which complement existing guidelines and help clinicians to reorganize their patients' list in the long term with a personalized medicine approach, in the context of health crisis or not.

Indexed as

NeurologyPatient SelectionUrologyClinical ProtocolsHumansRisk AssessmentTime FactorsTriageUrinary Bladder, NeurogenicCOVID-19GuidelinesNeuro-urologyPractice managementPrioritization

Identifiers

PMID34402945
PMCPMC8369873

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.